HBx inhibits CYP2E1 gene expression via downregulating HNF4α in human hepatoma cells

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Liu, Hongming ^a   Lou, Guiyu ^b   Li, Chongyi ^b   Wang, Xiaodong ^c,d   Cederbaum, Arthur I ^c   Gan, Lixia ^b   Xie, Bin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Chongqing Biomean Technology Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2E1; HEPATITIS B VIRUS X PROTEIN; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 4;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; LIVER TUMOR; TUMOR CELL LINE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYTOCHROME P-450 CYP2E1; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LIVER NEOPLASMS; MICE; MICE, KNOCKOUT;

EID: 84907220654     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107913     Document Type: Article

References (48)

1. Schutte K, Bornschein J, Malfertheiner P (2009) Hepatocellular carcinoma epidemiological trends and risk factors. Dig Dis 27: 80-92
2. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576
3. Chen M, Therneau T, Orsini LS, Qiao YL (2011) Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma. BMC Gastroenterol 11: 53-60
4. Kew MC (2010) Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris) 58: 273-277
5. Brechot C, Kremsdorf D, Soussan P, Pineau P, Dejean A, et al. (2010) Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms. Pathol Biol (Paris) 58: 278-287
6. Ng SA, Lee C (2011) Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol 46: 974-990
7. Cederbaum AI (2010) Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity. Dig Dis 28: 802-811
8. Wang JF, Chou KC (2010) Molecular modeling of cytochrome P450 and drug metabolism. Curr Drug Metab 11: 342-346
9. Bie'che I, Narjoz C, Asselah T, Vacher S, Marcellin P, et al. (2007) Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17: 731-742
10. Cederbaum AI (2012) Alcohol metabolism. Clin Liver Dis 16: 667-685
11. Wang Z, Hall SD, Maya JF, Li L, Asghar A, et al. (2003) Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br J Clin Pharmacol 55: 77-85
12. Novak RF, Woodcroft KJ (2000) The alcohol-inducible form of cytochrome P450 (CYP2E1): role in toxicology and regulation of expression. Arch Pharm Res 23: 267-282
13. Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 59- flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110: 559-565
14. Zeng T, Guo FF, Zhang CL, Song FY, Zhao XL, et al. (2013) Roles of cytochrome P4502E1 gene polymorphisms and the risks of alcoholic liver disease: a meta-analysis. PLoS One 8: e54188
15. Kinoshita M, Miyata M (2002) Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci. Hepatology 36: 433-438
16. Man XB, Tang L, Qiu XH, Yang LQ, Cao HF, et al. (2004) Expression of cytochrome P4502E1 gene in hepatocellular carcinoma. World J Gastroenterol 10: 1565-1568
17. Ho JC, Cheung ST, Leung KL, Ng IO, Fan ST (2004) Decreased expression of cytochrome P450 2E1 is associated with poor prognosis of hepatocellular carcinoma. Int J Cancer 111: 494-500
18. Schrem H, Klempnauer J, Borlak J (2002) Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev 54: 129-158
19. Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, et al. (2003) Hepatocyte nuclear factor 4a controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 34: 292-296
20. Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, et al. (2006) Hepatocyte nuclear factor 4a orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci U S A 103: 8419-8424
21. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, et al. (2004) Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 39: 1038-1047
22. Lazarevich NL, Shavochkina DA, Fleishman DI, Kustova IF, Morozova OV, et al. (2010) Deregulation of hepatocyte nuclear factor 4 (HNF4) as a marker of epithelial tumors progression. Exp Oncol 32: 167-171
23. Ning BF, Ding J, Yin C, Zhong W, Wu K, et al. (2010) Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res 70: 7640-7651
24. Yin C, Lin Y, Zhang X, Chen YX, Zeng X, et al. (2008) Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology 48: 1528-1539
25. Long Y, Chen E, Liu C, Huang F, Zhou T, et al. (2009) The correlation of hepatocyte nuclear factor 4 alpha and 3 beta with hepatitis B virus replication in the liver of chronic hepatitis B patients. J Viral Hepat 16: 537-546
26. Chen EQ, Sun H, Feng P, Gong DY, Liu C, et al. (2012) Study of the expression levels of Hepatocyte nuclear factor 4 alpha and 3 beta in patients with different outcome of HBV infection. Virol J 9: 23-28
27. Hosel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, et al. (2009) Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50: 1773-1782
28. Li L, Oropeza CE, Sainz B Jr, Uprichard SL, Gonzalez FJ, et al. (2009) Developmental regulation of hepatitis B virus biosynthesis by hepatocyte nuclear factor 4alpha. PLoS One 4: e5489
29. Chen Y, Goldstein JA (2009) The transcriptional regulation of the human CYP2C genes. Curr Drug Metab 10: 567-578
30. Lee CW, Kuo WL, Yu MC, Chen TC, Tsai CN, et al. (2013) The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection. World J Surg Oncol 11: 136-147
31. Chen YW, Chu HC, Lin ZS, Shiah WJ, Chou CP, et al. (2013) P16 Stimulates CDC42-dependent migration of hepatocellular carcinoma cells. PLoS One 8: e69389
32. Cederbaum AI, Lu Y, Wu D (2009) Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 83: 519-548
33. Lu Y, Wu D, Wang X, Ward SC, Cederbaum AI (2010) Chronic alcoholinduced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Free Radic Biol Med 49: 1406-1416
34. Chen Q, Galleano M, Cederbaum AI (1997) Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1. J Biol Chem 272: 14532-14541
35. Wu D, Cederbaum AI (1999) Ethanol-induced apoptosis to stable HepG2 cell lines expressing human cytochrome P-4502E1. Alcohol Clin Exp Res 23: 67-76
36. Wu D, Cederbaum AI (2013) Inhibition of autophagy promotes CYP2E1- dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and JNK MAPK. Redox Biol 1: 552-565
37. Liu SY, Gonzalez FJ (1995) Role of the liver-enriched transcription factor HNF- 1 alpha in expression of the CYP2E1 gene. DNA Cell Biol 14: 285-293
38. Peng HM, Coon MJ (2000) Promoter function and the role of cytokines in the transcriptional regulation of rabbit CYP2E1 and CYP2E2. Arch Biochem Biophys 382: 129-137
39. Gonzalez FJ, Gelboin HV (1990) Transcriptional and posttranscriptional regulation of CYP2E1, an N-nitrosodimethylamine demethylase. Princess Takamatsu Symp 21: 157-164
40. Wang J, Hu Y, Nekvindova J, Ingelman-Sundberg M, Neve EP (2010) IL-4- mediated transcriptional regulation of human CYP2E1 by two independent signaling pathways. Biochem Pharmacol 80: 1592-1600
41. Akiyama TE, Gonzalez FJ (2003) Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors. Biochim Biophys Acta 1619: 223-234
42. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, et al. (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44: 707-715
43. Hakkola J, Hu Y, Ingelman-Sundberg M (2003) Mechanisms of down-regulation of CYP2E1 expression by inflammatory cytokines in rat hepatoma cells. J Pharmacol Exp Ther 304: 1048-1054
44. Hsu JL, Chuang WJ, Su IJ, Gui WJ, Chang YY, et al. (2013) Zinc-dependent interaction between JAB1 and pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis. J Virol 87: 12675-12684
45. Wiwi CA, Gupte M, Waxman DJ (2004) Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4alpha-deficient mice. Mol Endocrinol 18: 1975-1987
46. Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, et al. (2009) Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 50: 1392-1402
47. Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, et al. (2010) Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci Transl Med 2: 32ra35
48. Tian Y, Kuo CF, Chen WL, Ou JH (2012) Enhancement of hepatitis B virus replication by androgen and its receptor in mice. J Virol 86: 1904-1910